Table 1.

Summary of used viral doses in this study

Viral dose levels (×1011 VP)
Single treatments (n = 39)
Serial treatments (n = 21)
All single CGTG-102 treatments (n = 72)a776
All serial CGTG-102 treatments (n = 51)a111
  • a8 patients received both single and serial treatment. Numbers in table indicate the numbers of treatments for each dose level.